Pacific Edge Limited (PFGTF) has released an update.
Pacific Edge Limited, a New Zealand-based global leader in bladder cancer diagnostics, has held its Annual Shareholder Meeting in Auckland, reflecting on a year of both significant achievements and challenges. Chairman Chris Gallaher, set to retire, highlighted the company’s dedication to delivering value to patients and shareholders, drawing on the personal story of a friend to underscore the impact of their Cxbladder diagnostic tests. Despite the hurdles, Gallaher expressed confidence in the future of the company and its technology, developed at Otago University, which is gaining trust globally.
For further insights into PFGTF stock, check out TipRanks’ Stock Analysis page.
